Renoprotective effects of renin–angiotensin–aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis. Reply to Catalá-López F [letter]
- 30 June 2012
- journal article
- letter
- Published by Springer Nature in Diabetologia
- Vol. 55 (9) , 2549-2550
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Renoprotective effects of renin–angiotensin–aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysisDiabetologia, 2012
- Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysisDiabetologia, 2011
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled studyDiabetologia, 2011
- Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysisThe Lancet, 2005
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001